Cargando…
Was the implementation strategy of the ProACT trial adequately proactive?
The ProACT trial does not inform the evidence base regarding safety and clinical effectiveness of procalcitonin (PCT) as a biomarker to guide antibiotic administration for LRTIs, but reveals potential challenges in the introduction of PCT in real life. http://ow.ly/Enfr30n2TK6
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395982/ https://www.ncbi.nlm.nih.gov/pubmed/30838064 http://dx.doi.org/10.1183/20734735.0338-2018 |
| _version_ | 1783399179729502208 |
|---|---|
| author | Mathioudakis, Alexander G. Vestbo, Jørgen |
| author_facet | Mathioudakis, Alexander G. Vestbo, Jørgen |
| author_sort | Mathioudakis, Alexander G. |
| collection | PubMed |
| description | The ProACT trial does not inform the evidence base regarding safety and clinical effectiveness of procalcitonin (PCT) as a biomarker to guide antibiotic administration for LRTIs, but reveals potential challenges in the introduction of PCT in real life. http://ow.ly/Enfr30n2TK6 |
| format | Online Article Text |
| id | pubmed-6395982 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63959822019-03-05 Was the implementation strategy of the ProACT trial adequately proactive? Mathioudakis, Alexander G. Vestbo, Jørgen Breathe (Sheff) Expert Opinion The ProACT trial does not inform the evidence base regarding safety and clinical effectiveness of procalcitonin (PCT) as a biomarker to guide antibiotic administration for LRTIs, but reveals potential challenges in the introduction of PCT in real life. http://ow.ly/Enfr30n2TK6 European Respiratory Society 2019-03 /pmc/articles/PMC6395982/ /pubmed/30838064 http://dx.doi.org/10.1183/20734735.0338-2018 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/ Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0 (http://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Expert Opinion Mathioudakis, Alexander G. Vestbo, Jørgen Was the implementation strategy of the ProACT trial adequately proactive? |
| title | Was the implementation strategy of the ProACT trial adequately proactive? |
| title_full | Was the implementation strategy of the ProACT trial adequately proactive? |
| title_fullStr | Was the implementation strategy of the ProACT trial adequately proactive? |
| title_full_unstemmed | Was the implementation strategy of the ProACT trial adequately proactive? |
| title_short | Was the implementation strategy of the ProACT trial adequately proactive? |
| title_sort | was the implementation strategy of the proact trial adequately proactive? |
| topic | Expert Opinion |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395982/ https://www.ncbi.nlm.nih.gov/pubmed/30838064 http://dx.doi.org/10.1183/20734735.0338-2018 |
| work_keys_str_mv | AT mathioudakisalexanderg wastheimplementationstrategyoftheproacttrialadequatelyproactive AT vestbojørgen wastheimplementationstrategyoftheproacttrialadequatelyproactive |